Ownership history in LBP AM SA · 11 quarters on record
This page tracks every 13F SEC filing in which LBP AM SA reported a position in BIOMARIN PHARMACEUTICAL INC (BMRN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 11,081 | -278 | -2.4% | 0.01% | $600K | $54.16 |
| 2025 Q2 | REDUCED | 11,359 | -666 | -5.5% | 0.01% | $624K | $54.97 |
| 2025 Q1 | ADDED | 12,025 | +6,576 | +120.7% | 0.01% | $850K | $70.69 |
| 2024 Q4 | REDUCED | 5,449 | -11,237 | -67.3% | 0.00% | $358K | $65.73 |
| 2024 Q3 | ADDED | 16,686 | +5,517 | +49.4% | 0.02% | $1.2M | $70.29 |
| 2024 Q2 | ADDED | 11,169 | +1,117 | +11.1% | 0.04% | $920K | $82.33 |
| 2024 Q1 | REDUCED | 10,052 | -225,450 | -95.7% | 0.03% | $878K | $87.34 |
| 2023 Q4 | UNCHANGED | 235,502 | — | 0% | 0.50% | $22.7M | $96.42 |
| 2023 Q3 | REDUCED | 235,502 | -732 | -0.3% | 0.46% | $20.8M | $88.48 |
| 2023 Q2 | REDUCED | 236,234 | -17,939 | -7.1% | 0.48% | $20.5M | $86.68 |
As of 2025 Q4 — sorted by position size